neovacs (ALNEV:Euronext Paris)
Chief Executive Officer, Neovacs S.A.
|Age||Total Calculated Compensation||This person is connected to 27 board members in 2 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Miguel Sieler serves as a Venture Partner at Truffle Capital. Mr. Sieler focuses on life sciences. Mr. Sieler served as Chief Executive Officer at Neovacs S.A. since October 17, 2013 and its General Director since October 2013. He served as Chairman and Chief Executive Officer of Bayer France. Mr. Sieler served in various senior positions at Bayer Group from 1975 to 2008. He served as the Chief Executive Officer of Bayer Pharma from 1995 to 1998 and at Bayer Group ...
3-5, Impasse ReillePhone: 33 1 53 10 93 00
Paris, Ile-de-France 75014
Fax: 33 1 53 10 93 03
Board Members Memberships*
Director, Chairman of Compensation & Appointments Committee and Member of Audit & Accounts Committee
Eberhard Karls Universität Tübingen
Institut d'Etudes Politiques de Paris
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|